1. Home
  2. TROO vs CRBP Comparison

TROO vs CRBP Comparison

Compare TROO & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

HOLD

Current Price

$1.93

Market Cap

151.5M

Sector

Technology

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.33

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROO
CRBP
Founded
2005
2009
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
151.5M
170.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TROO
CRBP
Price
$1.93
$8.33
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$50.29
AVG Volume (30 Days)
93.3K
495.7K
Earning Date
12-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,084,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
247.24
N/A
52 Week Low
$0.49
$4.64
52 Week High
$2.62
$20.56

Technical Indicators

Market Signals
Indicator
TROO
CRBP
Relative Strength Index (RSI) 67.65 30.77
Support Level $1.82 $7.97
Resistance Level $2.27 $8.51
Average True Range (ATR) 0.22 0.62
MACD 0.02 -0.02
Stochastic Oscillator 59.56 8.99

Price Performance

Historical Comparison
TROO
CRBP

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: